scholarly article | Q13442814 |
P50 | author | Ivan Rychlík | Q61138620 |
Kai-Uwe Eckardt | Q77053619 | ||
P2093 | author name string | Amandine Perrin | |
Iain C Macdougall | |||
David Van Wyck | |||
Andreas H Bock | |||
Fernando Carrera | |||
Simon D Roger | |||
Sylvain Larroque | |||
Yvonne Meier | |||
Carlo Gaillard | |||
P2860 | cites work | Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis | Q26822051 |
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia | Q34041146 | ||
New insights into the regulation of iron homeostasis | Q34516972 | ||
Individualized treatment for iron-deficiency anemia in adults | Q34866851 | ||
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients | Q34885195 | ||
Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients | Q35003742 | ||
Iron therapy for renal anemia: how much needed, how much harmful? | Q35650627 | ||
Association of genetic variants with response to iron supplements in pregnancy | Q35666115 | ||
Ferumoxytol for treating iron deficiency anemia in CKD | Q36796801 | ||
Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004. | Q37042142 | ||
Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous? | Q37656315 | ||
The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale | Q37668885 | ||
Total dose iron infusion: safety and efficacy in predialysis patients. | Q40624923 | ||
Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. | Q50733265 | ||
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. | Q51035442 | ||
A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease | Q54989527 | ||
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD | Q81549416 | ||
Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis | Q81639422 | ||
Within-patient variation of hemoglobin and reticulocytes: implications for evaluating ESA responsiveness in dialysis patients | Q84307547 | ||
Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysis | Q84575212 | ||
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients | Q84611960 | ||
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate | Q84778579 | ||
Chapter 2: Use of iron to treat anemia in CKD | Q87393429 | ||
P433 | issue | 12 | |
P921 | main subject | chronic renal insufficiency | Q736715 |
P304 | page(s) | 301-310 | |
P577 | publication date | 2017-12-01 | |
P1433 | published in | Clinical Nephrology | Q15763520 |
P1476 | title | Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial | |
P478 | volume | 88 |
Q88035892 | Ferric Carboxymaltose: A Review in Iron Deficiency |
Q52633750 | Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia. |
Q58700150 | Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease |
Q57167424 | Intravenous Irons: From Basic Science to Clinical Practice |
Q91798034 | Parenteral versus oral iron therapy for adults and children with chronic kidney disease |
Q57030706 | Sucrosomial Iron: A New Generation Iron for Improving Oral Supplementation |
Search more.